COMP <GO>
IRTC vs ICUI // ENTERPRISE SCALE & MARKET CAP
iRhythm Holdings Inc. (NASDAQ) VS. ICU Medical Inc. (NASDAQ) • 15-METRIC TALLY: IRTC 3
— ICUI 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ICUI
LAST: $127.80 (+3.07%) • MKT CAP: $4.21B
market-cap
$4.21B
LAST: $168.65 (+1.36%) • MKT CAP: $4.22B
market-cap
$4.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRTC VS. ICUI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRTC | ICUI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.60% | 36.80% | +33.80 | IRTC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.50% | 1.00% | -14.50 | ICUI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 46.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.82% | 2.18% | -1.36 | ICUI | /fcf-yield <GO> |
| Operating Margin | -7.70% | 1.90% | -9.60 | ICUI | /operating-margins <GO> |
| Net Profit Margin | -6.00% | 0.00% | -6.00 | ICUI | /net-margins <GO> |
| Revenue Growth (YoY) | 26.20% | -6.30% | +32.50 | IRTC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.01 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | ICUI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.2 | 56.5 | +11.70 | IRTC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $4.21B | $4.22B | -$4.8M | ICUI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRTC REV | ICUI REV | IRTC GROSS % | ICUI GROSS % | IRTC FCF | ICUI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $747.1M | $2.23B | 70.6% | 36.8% | $34.5M | $91.8M |
| FY 2024 | $591.8M | $2.38B | 68.9% | 34.6% | -$30.6M | $124.7M |
| FY 2023 | $492.7M | $2.26B | — | — | -$72.3M | $166.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRTC // BETA 0.98
ICUI // BETA —